BeOne Medicines AG (ONC)

BeOne Medicines AG Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Operating Revenue	1,680	1,487	1,476	1,395	1,302	1,109	1,118	993.45	929.17	751.65	643.04	721.49	595.26	447.8	380.1	387.63	341.57	306.63	213.98	206.44
Other Revenue	25.28	26.11	21.73	17.27	13.22	8.75	9.79	8.15	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	1,705	1,513	1,498	1,412	1,315	1,117	1,128	1,002	929.17	751.65	643.04	721.49	595.26	447.8	380.1	387.63	341.57	306.63	213.98	206.44
Revenue Growth (YoY)	29.63%	35.46%	32.84%	41.00%	41.56%	48.64%	75.39%	38.82%	56.09%	67.85%	69.18%	86.13%	74.27%	46.04%	77.63%	87.77%	127.73%	-49.39%	113.77%	126.66%
Cost of Revenue	174.53	167.22	142.42	196.51	164.61	165	160.56	170.46	138.13	124.94	111.92	82.66	95.99	81.79	-1,121	502.91	449.38	455.15	479.03	399.35
Gross Profit	1,531	1,346	1,356	1,216	1,151	952.28	967.26	831.14	791.03	626.72	531.11	638.83	499.27	366.01	1,501	-115.28	-107.81	-148.53	-265.05	-192.91
Selling, General & Admin	593.21	555.1	555.29	529	537.91	459.29	504.68	455.22	443.73	427.43	404.63	349.52	395.03	328.5	329.8	322.89	331.4	294.57	308.06	269.23
Research & Development	612.28	541.22	615.42	523.66	524.9	481.89	542.01	496.18	454.47	460.64	484.34	426.42	422.76	408.58	1,641	-	-	-	-	-
Amortization of Goodwill & Intangibles	-	-	-	-	-	-	-	-	-	-	-	-	0.19	0.19	0.19	0.19	0.19	0.19	0.19	0.19
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	23.87	-23.2	-	-	-	-	-	-	-	-
Operating Expenses	1,205	1,096	1,171	1,053	1,063	941.18	1,047	951.4	898.2	888.07	912.56	752.64	817.99	737.27	1,970	323.08	331.59	294.76	308.24	269.42
Operating Income	325.05	249.9	185.04	163.11	87.89	11.1	-79.43	-120.27	-107.16	-261.35	-381.45	-113.81	-318.72	-371.26	-469.43	-438.36	-439.4	-443.29	-573.3	-462.33
Interest Expense	-39.74	-32.89	-32.47	-10.76	-8	-7	-7.55	-6.14	-4.92	-3.2	-	-	-4.46	-4.23	-4.99	-5.07	-4.8	-4.25	-6.55	-7.33
Interest & Investment Income	27.9	27.66	32.37	13.79	11.49	12.85	15.36	16.78	18.15	19.36	24.4	17.12	19.53	20.25	23.21	17.83	16.23	14.32	2.07	5.1
Earnings From Equity Investments	-1.2	-0.01	0.87	-0.58	-1.9	-13.38	-2.47	-2.94	-4.02	-0.86	-7.86	2.62	-2.48	-0.14	-1.09	-1.36	-0.65	-0.59	-0.58	-0.56
Currency Exchange Gain (Loss)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-118.36	-	-	-
Other Non Operating Income (Expenses)	-2.68	14.54	4.16	-4.77	13.19	19.38	-4.7	13.76	-7.35	1.09	-320.12	316.06	-61.81	18.47	25.83	-126.03	-4.74	28.97	0.62	8.28
EBT Excluding Unusual Items	309.33	259.22	189.96	160.8	102.67	22.96	-78.78	-98.8	-105.3	-244.95	-685.03	222	-367.93	-336.91	-426.47	-552.99	-551.71	-404.83	-577.74	-456.84
Gain (Loss) on Sale of Investments	3.13	-	-40.72	-13.64	-3.13	-2.06	-6.57	0.49	-0.62	-2.21	0.88	-7.98	0.47	-0.03	-4.49	1.75	-5.88	-16.42	-9.07	23.76
Gain (Loss) on Sale of Assets	-	-	-	-	-	-	-	-	-	3.74	-0.07	0.06	-	-	-	-	-	-	-	-
Asset Writedown	-	-	-	-	-	-	-	-	-	-	0.81	-0.78	-	-	-	-	-	-	-	-
Other Unusual Items	-	-	-	-	-	-	-	-	-	-	362.92	-	-	-	-	-	-	-	-	-
Pretax Income	312.46	259.22	149.24	147.16	99.55	20.9	-85.35	-98.3	-105.92	-243.43	-320.49	213.3	-367.46	-336.94	-430.97	-551.24	-557.59	-421.25	-586.8	-433.08
Income Tax Expense	75.45	31.86	82.74	22.32	5.23	19.63	66.53	23.05	14.49	7.72	14.31	15.23	13.67	11.49	14.37	6.32	8.14	13.95	3.87	5.04
Earnings From Continuing Operations	237.01	227.36	66.5	124.84	94.32	1.27	-151.88	-121.35	-120.41	-251.15	-334.79	198.07	-381.14	-348.43	-445.34	-557.56	-565.73	-435.2	-590.68	-438.11
Net Income	237.01	227.36	66.5	124.84	94.32	1.27	-151.88	-121.35	-120.41	-251.15	-334.79	198.07	-381.14	-348.43	-445.34	-557.56	-565.73	-435.2	-590.68	-438.11
Net Income to Common	237.01	227.36	66.5	124.84	94.32	1.27	-151.88	-121.35	-120.41	-251.15	-334.79	198.07	-381.14	-348.43	-445.34	-557.56	-565.73	-435.2	-590.68	-438.11
Net Income Growth (YoY)	151.28%	17802.13%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Shares Outstanding (Basic)	112	111	111	110	108	107	106	106	105	104	104	105	105	104	104	103	103	102	95	93
Shares Outstanding (Diluted)	116	116	115	115	113	111	106	106	105	104	104	105	105	104	104	103	103	102	95	93
Shares Change (YoY)	2.88%	4.14%	8.58%	8.13%	7.51%	6.62%	2.10%	0.66%	0.06%	0.10%	0.30%	1.67%	1.78%	1.66%	9.19%	11.55%	11.91%	5.93%	4.60%	4.96%
EPS (Basic)	2.12	2.05	0.60	1.13	0.87	0.01	-1.43	-1.15	-1.15	-2.41	-3.22	1.88	-3.64	-3.34	-4.29	-5.39	-5.50	-4.25	-6.22	-4.72
EPS (Diluted)	2.08	1.95	0.52	1.04	0.78	0.01	-1.44	-1.17	-1.17	-2.47	-3.22	1.88	-3.64	-3.34	-4.35	-5.39	-5.50	-4.25	-6.28	-4.72
EPS Growth (YoY)	166.67%	16970.81%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Additional Metrics

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Free Cash Flow	435.34	160.55	379.83	354.47	219.77	-12.33	-17.32	54.71	-205.54	-465.15	-520.82	-60.02	-415.36	-689.36	-439.55	-670.56	-430.25	-281.69	-622.82	-562.76
Free Cash Flow Per Share	3.76	1.39	3.29	3.10	1.95	-0.11	-0.16	0.52	-1.96	-4.46	-5.00	-0.57	-3.97	-6.62	-4.24	-6.48	-4.18	-2.75	-6.55	-6.07
Gross Margin	89.76%	88.95%	90.49%	86.09%	87.48%	85.23%	85.76%	82.98%	85.13%	83.38%	82.59%	88.54%	83.87%	81.73%	394.92%	-29.74%	-31.56%	-48.44%	-123.87%	-93.45%
Operating Margin	19.06%	16.51%	12.35%	11.55%	6.68%	0.99%	-7.04%	-12.01%	-11.53%	-34.77%	-59.32%	-15.77%	-53.54%	-82.91%	-123.50%	-113.09%	-128.64%	-144.57%	-267.92%	-223.95%
Profit Margin	13.90%	15.02%	4.44%	8.84%	7.17%	0.11%	-13.47%	-12.12%	-12.96%	-33.41%	-52.06%	27.45%	-64.03%	-77.81%	-117.16%	-143.84%	-165.62%	-141.93%	-276.05%	-212.22%
Free Cash Flow Margin	25.53%	10.61%	25.35%	25.10%	16.71%	-1.10%	-1.54%	5.46%	-22.12%	-61.88%	-80.99%	-8.32%	-69.78%	-153.94%	-115.64%	-172.99%	-125.96%	-91.87%	-291.06%	-272.60%
EBITDA	363.97	289.3	219.47	198.86	117.75	42.73	-30.36	-50.16	-83.41	-237.24	-358.75	-93.28	-297.22	-352.05	-452.2	-422.96	-424.75	-427.52	-560.81	-450.36
EBITDA Margin	21.35%	19.12%	14.65%	14.08%	8.95%	3.82%	-2.69%	-5.01%	-8.98%	-31.56%	-55.79%	-12.93%	-49.93%	-78.62%	-118.97%	-109.11%	-124.35%	-139.43%	-262.08%	-218.16%
D&A For EBITDA	38.92	39.4	34.44	35.75	29.87	31.63	49.06	70.11	23.75	24.11	22.7	20.53	21.5	19.21	17.24	15.4	14.65	15.77	12.49	11.96
EBIT	325.05	249.9	185.04	163.11	87.89	11.1	-79.43	-120.27	-107.16	-261.35	-381.45	-113.81	-318.72	-371.26	-469.43	-438.36	-439.4	-443.29	-573.3	-462.33
EBIT Margin	19.06%	16.51%	12.35%	11.55%	6.68%	0.99%	-7.04%	-12.01%	-11.53%	-34.77%	-59.32%	-15.77%	-53.54%	-82.91%	-123.50%	-113.09%	-128.64%	-144.57%	-267.92%	-223.95%
Effective Tax Rate	24.15%	12.29%	55.44%	15.17%	5.25%	93.92%	-	-	-	-	-	7.14%	-	-	-	-	-	-	-	-
Revenue as Reported	1,705	1,513	1,498	1,412	1,315	1,117	1,128	1,002	929.17	751.65	643.04	721.49	595.26	447.8	380.1	387.63	341.57	306.63	213.98	206.44

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 17, 2026

Data Sources Report a data error